Vista Pharmaceuticals Limited (BOM:524711)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Manufacturing of Pharmaceutical Products	100.75M	102.88M	10.04M	3.95M	12.66M
Manufacturing of Pharmaceutical Products Growth	-2.07%	924.99%	154.42%	-68.85%	-94.44%
Total	100.75M	102.88M	10.04M	3.95M	12.66M
Total Growth	-2.07%	924.99%	154.42%	-68.85%	-94.44%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
India	100.75M	102.88M	10.04M	3.95M	12.66M
India Growth	-2.07%	924.99%	154.42%	-68.85%	-94.44%
Total	100.75M	102.88M	10.04M	3.95M	12.66M
Total Growth	-2.07%	924.99%	154.42%	-68.85%	-94.44%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error